ClinicalTrials.Veeva

Menu

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes (ANODE04)

G

Glyconics

Status

Not yet enrolling

Conditions

Healthy
Diabetes Mellitus

Treatments

Device: Near-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nail

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT07039357
NIRDM-SXCIP04

Details and patient eligibility

About

A single-site, open label, confirmatory study assessing two biomarkers indicative of levels of glycaemia; glycated keratin in fingernails and glycated haemoglobin (HbA1c). Screening for diabetes

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Apparently healthy adults (≥18 years of age) with known (n=50) or unknown T2DM status (n=50) willing to participate in and provide a written consent for the study
  • willingness to undertake assisted assessment of glycaemia by both the NIR spectra measurement, and HbA1c by finger prick test
  • Individuals with at least one visually assessed undamaged, intact (preferably middle) fingernail

Exclusion criteria

  • Individuals with any known medical conditions impacting the PoC device assessment methodology for glycaemia, such as

    • Severe forms of anaemia (diagnosed iron deficiency, sickle cell anaemia or similar)
    • haemoglobinopathies or atypical haemoglobin subtypes not detectable by the assay
    • severe renal impairment (CKD stage III-IV) or decompensated hepatic disease
    • severe Vitamin D deficiency (diagnosed or measured 25(OH)D3 < 25 nmol/ml)
    • known severe immunodeficiency such as HIV, malignancy or other chronic condition significantly impacting assessment of glycaemia
    • eating disorders (as per clinical assessment)
    • recent (within 28 days) blood donation
    • known / diagnosed other diabetes such as T1DM, GDM, MODY, etc.
  • For the Glyconics-DS device / targeted nail:

    • Mechanical damage or marks on the surface of the nail after removal of nail polish, or
    • Use of acrylic or gel nail decoration and polish, which cannot be removed.

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Apparently healthy volunteers without known diabetes
Experimental group
Description:
Both methods for assessment of glycaemia will be applied in this group as well
Treatment:
Device: Near-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nail
People with known T2DM
Experimental group
Description:
Both methods for assessment of glycaemia will be applied in this group as well
Treatment:
Device: Near-infrared (spectroscopy) for non-invasive assessment of glycated keratin of nail

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems